Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Fish and Richardson
Chinese Patent Office
Express Scripts
US Department of Justice

Generated: July 20, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,733,569

« Back to Dashboard

Summary for Patent: 5,733,569

Title: Galenic compositions comprising calcitonin and their use
Abstract:Pharmaceutical compositions for nasal administration comprising i) a calcitonin, and ii) benzalkonium chloride, and/or iv) a surfactant, suitable for application to the nasal mucosa, in iii) a liquid diluent or carrier, suitable for application to the nasal mucosa. The compositions are suitably adapted for administration in the form of a nasal spray.
Inventor(s): Azria; Moise (Basel, CH), Cavanak; Thomas (Biel-Benken, CH)
Assignee: Novartis Corporation (Summit, NJ)
Application Number:08/471,118
Patent Claim Types:
see list of patent claims
Composition; Delivery; Device; Use;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,733,569

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom8228390Oct 05, 1982
Japan8236928Dec 30, 1982
United Kingdom8320865Aug 03, 1983
United Kingdom8322528Aug 22, 1983

International Patent Family for Patent: 5,733,569

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
HungaryT34121► Subscribe
Hong Kong27389► Subscribe
Switzerland657779► Subscribe
Cyprus1466► Subscribe
Germany3335086► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Harvard Business School
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:

Google Plus